The prognosis for Stage IV cancer varies widely depending on the type of cancer, the extent of metastasis, and the patient’s overall health. Generally, the prognosis is poor due to the advanced nature of the disease. However, advancements in targeted therapies, immunotherapy, and personalized medicine are improving outcomes for some patients.
